Snowball logo
logo
RJF_logo

Laboratorio Reig Jofre S.A

RJF MC
2.67-0.01  (0.37%)
Estimate
P/E
33.4
EPS
0.08
Beta
0.947
Growth
Revenue, YoY
1.1%
Net income, YoY
117.64%
Forecast
P/E (FWD)
22.3
EPS (FWD)
0.12
Dividends
Dividend yield
0.73%
Annual payout
0.02
Next ex. div date
May 21, 27
Payout
0.64%
Div.growth, 5y
4.67%
Div.rating
About the company
Ticker
RJF
ISIN
ES0165359029
Country
Spain
Sector (GICS)
Healthcare
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Frequently asked questions

What sector does Laboratorio Reig Jofre S.A (RJF) operate in?

Laboratorio Reig Jofre S.A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Laboratorio Reig Jofre S.A (RJF) current stock price?

As of the latest data, Laboratorio Reig Jofre S.A stock price is €2.67, with a previous close of €2.68. Laboratorio Reig Jofre S.A lost -€0.01 in the last trading session, representing a -0.37% loss.

What is Laboratorio Reig Jofre S.A (RJF) current market capitalization?

Laboratorio Reig Jofre S.A market cap is approximately 219.12 million.

What is Laboratorio Reig Jofre S.A (RJF) Earnings Per Share (EPS)?

The trailing EPS is €0.08, and the forward EPS is €0.12.

What is Laboratorio Reig Jofre S.A (RJF) Price-to-Earnings (P/E) ratio?

Laboratorio Reig Jofre S.A current P/E ratio is 33.38, with a forward P/E of 22.25.

What is Laboratorio Reig Jofre S.A (RJF) EBITDA?

Laboratorio Reig Jofre S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 8.00 million.

Does Laboratorio Reig Jofre S.A (RJF) pay dividends?

Yes. Laboratorio Reig Jofre S.A pays annual dividends with an annualized yield of 0.73% and an estimated annual payout of €0.02 per share.

When is the next ex-dividend date for Laboratorio Reig Jofre S.A (RJF)?

The next ex-dividend date is scheduled for May 21, 2027.

What is Laboratorio Reig Jofre S.A (RJF) beta (volatility) score?

Laboratorio Reig Jofre S.A has a beta of 0.947, meaning its volatility is roughly in line with the market.